Duncan-Williams Reiterates Buy on Exactech (EXAC)

Duncan-Williams is out with its report on Exactech EXAC, reiterating Buy. In a note to clients, Duncan-Williams writes, "We are maintaining our 2011 revenue and EPS estimates of $207 million and $1.15, respectively. This represents 9% revenue growth and 34% EPS growth compared to 2010. We are reiterating our BUY rating on EXAC and are maintaining our twelve month price target of $23.00. Our price target is 20 times our 2011 EPS estimate of $1.15." Shares of EXAC closed Monday at $17.35.